CORC

在结果中检索

CORC

浏览/检索结果: 共29条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
Discovery of a highly potent kinase inhibitor capable of overcoming multiple imatinib-resistant ABL mutants for chronic myeloid leukemia (CML) 期刊论文
EUROPEAN JOURNAL OF PHARMACOLOGY, 2021, 卷号: 897
作者:  Lu, Tingting;  Cao, Jiangyan;  Zou, Fengming;  Li, Xixiang;  Wang, Aoli
收藏  |  浏览/下载：42/0  |  提交时间：2021/04/26
YES1amplification confers trastuzumab-emtansine (T-DM1) resistance in HER2-positive cancer 期刊论文
BRITISH JOURNAL OF CANCER, 2020, 页码: 12
作者:  Wang, Lei;  Wang, Quanren;  Xu, Piaopiao;  Fu, Li;  Li, Yun
收藏  |  浏览/下载：15/0  |  提交时间：2020/12/24
Discovery and characterization of a novel highly potent and selective type II native and drug-resistant V299L mutant BCR-ABL inhibitor (CHMFL-ABL-039) for Chronic Myeloid Leukemia (CML) 期刊论文
CANCER BIOLOGY & THERAPY, 2019, 卷号: 20, 期号: 6, 页码: 877-885
作者:  Wu, Jiaxin;  Wang, Aoli;  Li, Xixiang;  Chen, Cheng;  Qi, Ziping
收藏  |  浏览/下载：29/0  |  提交时间：2019/11/27
Four-year follow-up of patients with imatinib-resistant or intolerant chronic myeloid leukemia receiving dasatinib: efficacy and safety 期刊论文
2019, 卷号: 13, 期号: 3, 页码: 344-353
作者:  Huang, Xiaojun;  Jiang, Qian;  Hu, Jianda;  Li, Jianyong;  Jin, Jie
收藏  |  浏览/下载：15/0  |  提交时间：2020/01/03
Inhibition of SRC family kinases facilitates anti-CTLA4 immunotherapy in head and neck squamous cell carcinoma 期刊论文
CELLULAR AND MOLECULAR LIFE SCIENCES, 2018, 卷号: 75, 期号: 22
作者:  Yu, Guang-Tao;  Mao, Liang;  Wu, Lei;  Deng, Wei-Wei;  Bu, Lin-Lin
收藏  |  浏览/下载：7/0  |  提交时间：2019/12/05
Dasatinib synergizes with ATRA to trigger granulocytic differentiation in ATRA resistant acute promyelocytic leukemia cell lines via Lyn inhibition-mediated activation of RAF-1/MEK/ERK 期刊论文
FOOD AND CHEMICAL TOXICOLOGY, 2018, 卷号: Vol.119, 页码: 464-478
作者:  Ding, Ming;  Weng, Xiang-qin;  Sheng, Yan;  Wu, Jing;  Liang, Cui
收藏  |  浏览/下载：2/0  |  提交时间：2019/12/26
Dasatinib Versus Imatinib in Patients (Pts) with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Who Have Not Achieved an Optimal Response to 3 Months of Imatinib Therapy: Dascern 会议论文
BLOOD, 2018-11-29
作者:  Cortes, Jorge E.;  Jiang, Qian;  Wang, Jianxiang;  Weng, Jianyu;  Zhu, Huanling
收藏  |  浏览/下载：11/0  |  提交时间：2020/01/03
Dasatinib Versus Imatinib in Patients (Pts) with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Who Have Not Achieved an Optimal Response to 3 Months of Imatinib Therapy: Dascern 期刊论文
2018, 卷号: 132
作者:  Cortes, Jorge E.;  Jiang, Qian;  Wang, Jianxiang;  Weng, Jianyu;  Zhu, Huanling
收藏  |  浏览/下载：13/0  |  提交时间：2020/01/03
A tightly controlled Src-YAP signaling axis determines therapeutic response to dasatinib in renal cell carcinoma 期刊论文
THERANOSTICS, 2018, 卷号: 8, 期号: 12, 页码: 3256-3267
作者:  Sun, Jingya;  Wang, Xin;  Tang, Boyun;  Liu, Hongchun;  Zhang, Minmin
收藏  |  浏览/下载：45/0  |  提交时间：2019/01/08
Polymeric Immunoglobulin Receptor Promotes Tumor Growth in Hepatocellular Carcinoma 期刊论文
HEPATOLOGY, 2017, 卷号: 65, 期号: 6, 页码: 1948-1962
作者:  Yue, Xihua;  Ai, Jing;  Xu, Yang;  Chen, Yi;  Huang, Min
收藏  |  浏览/下载：34/0  |  提交时间：2019/01/08

©版权所有 ©2017 CSpace - Powered by CSpace